Mark B. Leick

Multiphoton Phosphorescence Quenching Microscopy Reveals Kinetics of Tumor Oxygenation during Antiangiogenesis and Angiotensin Signaling Inhibition

Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors

Durability of Vaccine-Induced and Natural Immunity Against COVID-19: A Narrative Review

A mosquito AgTRIO mRNA vaccine contributes to immunity against malaria

Engineered receptors for soluble cellular communication and disease sensing

Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance

Nanomaterials for T-cell cancer immunotherapy

Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells

CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?

Hepatocellular carcinoma

Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges

Programmable synthetic receptors: the next-generation of cell and gene therapies

Delivery technologies for T cell gene editing: Applications in cancer immunotherapy

CAR-T cell therapy: current limitations and potential strategies

Engineering strategies to overcome the current roadblocks in CAR T cell therapy

Hemophagocytic lymphohistiocytosis with immunotherapy: brief review and case report

CAR T-Cell-Based gene therapy for cancers: new perspectives, challenges, and clinical developments

Mechanisms of Insulin Action and Insulin Resistance

Sense-and-Respond Payload Delivery Using a Novel Antigen-Inducible Promoter Improves Suboptimal CAR-T Activation

Insulin Receptor Isoforms in Physiology and Disease: An Updated View

Ionizable Lipid Nanoparticles with Integrated Immune Checkpoint Inhibition for mRNA CAR T Cell Engineering

CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity

Toxicities associated with immunotherapies for hematologic malignancies

CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma

Differential T-Cell Immunity to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in mRNA-1273– and BNT162b2-Vaccinated Individuals

Loss of imprinting of IGF2 and the epigenetic progenitor model of cancer.